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Abstract
Background: Henoch-Schönlein syndrome is a systemic small-vessel leukocytoclastic vasculitis that usually present
with cutaneous, gastrointestinal, articular and renal manifestations. Little is known on liver involvement in this
syndrome. This study investigated liver chemistry and creatine kinase in Henoch-Schönlein children.
Case presentation: Alanine aminotransferase, aspartate aminotransferase, γ-glutamyltransferase, lactate
dehydrogenase, total bilirubin, prothrombin time and creatine kinase were assessed in 75 consecutive pediatric
patients (41 boys and 34 girls aged from 2.9 to 17 years) with new-onset Henoch-Schönlein syndrome. Mildly
altered values were found in 7 (9%) patients (5 boys and 2 girls aged from 3.3 to 17 years). In the mentioned cases,
all tests returned to normal at a 2–4-week follow-up.
Conclusions: This preliminary study points out that altered and self-remitting liver parameters occur in approximately
10% of children with Henoch-Schönlein syndrome.
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Background
Henoch-Schönlein syndrome, also called immunoglobu-
lin A vasculitis, is the most common systemic vasculitis
in childhood [1]. It is a small-vessel leukocytoclastic vas-
culitis that typically presents with cutaneous, gastro-
intestinal, articular and renal manifestations [1]. Little is
known on liver involvement in this syndrome. Limited
data suggest that aminotransferases are elevated in ap-
proximately 3% of children with new-onset Henoch-
Schönlein syndrome and in cases complicated by acalcu-
lous cholecystitis or pancreatitis [2, 3]. Exercise, infec-
tious prodromi or drugs with hepatotoxic potential or a
pre-existing liver disease, such as non-alcoholic fatty
liver disease, might also alter aminotransferases in
Henoch-Schönlein syndrome [4, 5]. Herein, we report
our prospective single-center experience with liver
chemistry and creatine kinase in 75 consecutive pediatric
patients affected by this vasculitis syndrome.
Study population and methods
Starting in 2009, at the Pediatric Emergency Unit,
Fondazione IRCCS Ca′ Granda Ospedale Maggiore
Policlinico, Milan, Italy, the initial laboratory approach to
new-onset Henoch-Schönlein cases included among others
the determination of liver chemistry (alanine aminotrans-
ferase, aspartate aminotransferase, γ-glutamyltransferase,
lactate dehydrogenase, total bilirubin and prothrombin
time) and creatine kinase in plasma. Urinalysis for
hematuria and proteinuria was also assessed.
In subjects with abnormal enzyme levels, plasma amyl-
ase was determined and a hepatobiliary ultrasound
performed. Finally, the blood tests were repeated ap-
proximately 2–4 weeks later.
The diagnosis of Henoch-Schönlein syndrome was
made using the Ankara 2008 - EULAR/PRINTO/PRES
criteria [6]. The CAAR grading system for cutaneous,
abdominal, articular, and renal involvement was applied
to assess the systemic disease activity [7].
From each case, we collected data on ethnicity, pre-
existing chronic conditions, possible triggers (defined as
acute illness or vaccination [1, 8] preceding the skin le-
sions by ≤14 days) and repetitive exercise ≤3 days before
admission to the emergency department. A careful drug
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history, including both prescribed and over-the-counter
medications, was also taken.
The liver and spleen borders were estimated clinically
at the end of inspiration: the liver border was deter-
mined by percussion and palpation in the right mid-
clavicular line and the diagnosis of hepatomegaly was
made when the liver edge projected >2 cm below the
margin [9]; the spleen border was determined by palpa-
tion in the left anterior axillary line and the diagnosis of
splenomegaly was made when the spleen was palpable
[10]. Finally, the Murphy sign was considered positive in
cases with pain on inspiration while palpating the right
upper abdominal quadrant.
A kinetic assay was used for alanine aminotransferase
(reference: <50 U/L), aspartate amintransferase (reference:
<50 U/L) and amylase (reference: <120 U/L), an ultraviolet
spectrophotometry for lactate dehydrogenase (reference:
<500 U/L) and creatine kinase (reference: <150 U/L), a
kinetic colorimetry for γ-glutamyltransferase (reference:
<50 U/L), a diazo colorimetry for total bilirubin (reference:
<20 μmol/L) and an automated clotting assay for pro-
thrombin time (reference: 0.90–1.30 INR). An automated
dipstick system was used for hematuria and proteinuria.
Enzyme values were graded as normal or mildly (<5
times the upper reference limit), moderately (5–10
times) and markedly (>10 times) altered. Data analysis
was approved of by the Ethical Committee of our hos-
pital. Anonymized patient information was used for data
analysis. Data are given either as median and interquar-
tile range or as relative frequency. The one-sample
Mann–Whitney–Wilcoxon test was used to compare the
results with those of the general population. Significance
was assumed when P < 0.05.
Case presentation
Between January 2009 and June 2016, we made the
diagnosis of new-onset Henoch-Schönlein syndrome
in 72 Caucasian and 3 Hispanic patients up to
17 years of age presented to the Pediatric Emergency
Unit. History, clinical findings and renal involvement
are given in Table 1. A possible trigger, either an in-
fection or a vaccination, was reported by 49 (65%) pa-
tients. Forty-one (55%) cases had been managed with
paracetamol, a nonsteroidal anti-inflammatory drug, a
penicillin or a macrolide.
The results of liver chemistry and creatine kinase ap-
pear in Fig. 1. As compared with the general population,
blood values were not abnormally elevated in Henoch-
Schönlein patients.
Enzyme levels were normal in 68 and mildly elevated
in the remaining 7 patients. None of them presented
with hepatomegaly, splenomegaly or Murphy sign. Cir-
culating amylase and hepatobiliary ultrasound were
found to be normal in these cases.
Table 1 History, clinical findings and renal involvement in 75
pediatric patients aged from 2.9 to 17 years with new-onset
Henoch-Schönlein syndrome. Data are given either as relative
frequency or as median and interquartile range
Age, years 6.4 [4.8–7.7]
Gender, ♂: ♀ 41: 34
Pre-existing chronic condition, N 0
Recent repetitive exercise 5
Triggers
Acute lower respiratory infection, N 15
Acute upper respiratory infection, N 14
Nonspecific febrile illness, N 10
Urinary tract infection, N 6
Acute diarrheal disease, N 3
Vaccination, N 1
Drug management
Paracetamol, N 31
Nonsteroidal anti-inflammatories, N 12
Penicillins, N 15
Macrolides, N 4
Clinical findings
Hepatomegaly, N 2
Splenomegaly, N 1
Hepatosplenomegaly, N 1
Murphy sign, N 0
Cutaneous involvement
Mild, N 47
Moderate, N 25
Severe, N 3
Abdominal involvement
None, N 28
Mild, N 28
Moderate, N 17
Severe, N 2
Articular involvement
None, N 14
Mild, N 46
Moderate, N 12
Severe, N 3
Renal involvement
None, N 45
Mild, N 22
Moderate, N 7
Severe, N 1
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An isolated increase in creatine kinase (175 and
189 U/L, respectively) was observed in two boys (7.5 and
9.3 years of age, respectively) with recent history of re-
petitive exercise. An increase in plasma creatine kinase
(265 U/L), associated with elevated alanine aminotransfer-
ase (60 U/L), aspartate aminotransferase (186 U/L) and
lactate dehydrogenase (523 U/L) was also observed in a
5.4-year-old boy with recent extended physical activity.
An altered liver chemistry was noted in further four
patients: a 6.7-year-old Caucasian male (alanine amino-
transferase 64 U/L, aspartate aminotransferase 65 U/L);
a 17-year-old Hispanic female (aspartate aminotransfer-
ase 53 U/L); a 6.2-year-old Caucasian male (lactate de-
hydrogenase 603 U/L); and a 3.3-year-old Caucasian girl
(lactate dehydrogenase level 540 U/L). Henoch-Schönlein
syndrome had been preceded by an upper (N = 2) or a
lower (N = 2) respiratory tract infection in these four pa-
tients and treatment with paracetamol 40–60 mg/kg body
weight daily had been recommended for fever, abdominal
pain or arthralgia.
At the 4-week follow-up, the parameters were normal
in the 7 patients with altered tests.
Discussion
This is the first prospective study investigating liver
chemistry and creatine kinase in unselected Henoch-
Schönlein children. These tests are normal at presenta-
tion in about 90% and mildly elevated in 10% of these
patients. In the latter cases, liver parameters are transi-
ently altered and self-remit within 4 weeks. Similar
Fig. 1 Liver parameters in 75 consecutive children with new-onset Henoch-Schönlein syndrome. An isolated increase in creatine kinase was
observed in two boys 7.5 and 9.3 years of age, respectively [orange circle; orange square]. Altered liver parameters were also noted in five
subjects: a 5.4-year-old Caucasian male [blue circle], a 6.7-year-old Caucasian male [green circle], a 17-year-old Hispanic female [gray circle],
a 6.2-year-old Caucasian male [lavender circle], and a 3.3-year-old Caucasian girl [aqua circle]
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observations were recently made in patients affected
with acute hemorrhagic edema of young children, the in-
fantile variant of Henoch-Schönlein syndrome [11].
Exercise likely accounts for the altered tests observed in
3 patients with recent history of extended physical activity
[4, 5]. On the contrary, we do not have a clear-cut explan-
ation for the transiently altered liver chemistry noted in
the remaining 4 cases. We speculate that altered liver tests
resulted either from the infectious prodrome or from un-
reported self-administration of a drug with hepatotoxic
potential. Finally, the strategy used to establish cut off
values implies that a result out of range is not necessarily
pathologic and is found in 2–3% of healthy subjects.
The findings of this study confirm those of a retrospect-
ive analysis including apparently unselected Henoch-
Schönlein children from the Republic of China [12]. In
that report, mildly elevated alanine aminotransferase levels
were observed in 9% of the cases. However, creatine kin-
ase levels were not assessed in those children.
Some months after starting the investigation presented
in this report, the use of lower laboratory thresholds for
alanine aminotranferase (i.e. 25 U/L instead of 50 U/L)
was proposed for children affected by a chronic liver dis-
ease [13]. This recommendation deserves in our opinion
further support.
The main limitations of this preliminary study were its
single center design, the rather small sample size and
the ethnic homogeneity of the study population.
Conclusions
This preliminary study points out that altered and self-
remitting liver chemistry or creatine kinase are found in
approximately 10% of children with Henoch-Schönlein
syndrome.
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